Introduction
============

Metabolic syndrome (MetS) is a constellation of cardiometabolic risk factors that contribute immensely to the burden of cardiovascular morbidity and mortality worldwide. The prevalence of MetS varies depending on the diagnostic criteria and study populations[@R1]--[@R3]. Due to epidemiologic transitions arising mainly from an unhealthy lifestyle, the incidence of MetS is on a steady rise in low and middle-income countries (LMICs), as well as high-income countries (HICs). Prevalence as much as 40% has been reported in some HICs, while in Nigeria it has been found to be about 30%[@R4],[@R5]. This burden is expected to increase in near future with it attendant high risk of cardiovascular disabilities and sudden deaths[@R6],[@R7].

Metabolic syndrome has been associated with sudden cardiac death (SCD).[@R8] In ARIC (Atherosclerosis Risk in Communities) Study, compared with participants without MetS, those with metabolic syndrome independent of race and ethnicity, had approximately 70% increased the risk of sudden cardiac death. Elevated blood pressure, impaired fasting glucose and low -density lipoprotein cholesterol as Mets components were shown to be the independent determinants of SCD.[@R9]

Interestingly, each of the components of MetS such as dyslipidemia, elevated blood pressure, insulin resistance ± glucose intolerance, as well as abdominal obesity has been shown to cause cardiac structural damages and arrhythmias[@R10]--[@R13]. Coexistence, therefore of MetS and ECG abnormalities may increase the risk of sudden cardiac death. However, there is a paucity of data on the association of cardiac arrhythmias and metabolic syndrome.[@R14] Early detection of these cardiac abnormalities using baseline 12 -lead ECG which is simple, noninvasive and cost -effective can help identify at-risk individuals for prompt and focused management.

Studies differ on the prevalence and associations of components of MetS with ECG abnormalities. In certain populations, a high prevalence of ECG abnormalities in metabolic syndrome were reported[@R10],[@R15]--[@R18]. While coronary artery disease and its attendant ECG changes have similar findings among Caucasians, and same are rarely reported among Africans[@R19],[@R20]. Despite the huge burden of stroke, heart failure and kidney failure in sub-Sahara Africa (SSA), data on ECG changes among metabolic syndrome patients alone are lacking. In order to address this gap and to show how ECG changes cluster among Africans with MetS, we report ECG changes in a Nigerian population with MetS compared to those without MetS.

Methods
=======

Subjects and methods
--------------------

This cross-sectional and comparative study was conducted over a period of one year from July 2014 to June 2015 following approval by the Joint University of Ibadan (UI)/University College Hospital (UCH) Ethics Committee approval reference number UI/EC/14/0136 dated 19^th^ June 2014. Four hundred and ninety-one adult patients with complete data for the diagnosis of metabolic syndrome and interpretable ECG tracings from CRP registry were studied. Cardiovascular Risk Prediction (CRP) is a registry of newly presenting patients into the cardiology division, medical out-patient department of University College Hospital Ibadan. The main aim of the registry is to risk stratify the patients at entry using Framingham and QRISK2 cardiovascular risk score for prompt management of at-risk individuals to prevent future cardiovascular morbidity and mortality.

Biodata of the participants was obtained using pretested questionnaires containing information on demographics, family history of cardiovascular diseases, life-styles and medication history. The contact information of the participants and their next of kin were obtained for communication during follow-up.

Assessment of anthropometric measurement
----------------------------------------

Anthropometric measurements including height, weight, waist and arm circumferences were obtained by trained nurses at the medical outpatient clinic. Height was measured without shoes to the nearest centimeter using a ruler attached to the wall. Weight was measured to the nearest 0.1kg on an electronic scale, with the subject wearing light outdoor clothing. Waist circumference was measured at the end of expiration at a mid-way between the rib cage and the iliac crest using an anthropometric measuring tape. Average of three measured waist circumferences, recorded to the nearest tenth of a centimeter was obtained for analysis.

Obesity was classified based on BMI in kg/m^2^ as normal (\>20 and \<25), overweight (\>25 and \<30), obesity (\>30 and \<35) and severe obesity (≥35)21. Abdominal obesity was defined based on the International Diabetic Federation (IDF) criteria using waist circumference (≥94cm (men), ≥80cm (female). Participants were further categorized as normal risk (men \<94cm; women \<80 cm), increased risk (men 94--102cm; women 80--88 cm), or substantially increased risk (men \>102cm; women \>88 cm) on the basis of the World Health Organization\'s standards for increased health risk associated with waist circumference[@R22],[@R23].

Assessment of blood pressure
----------------------------

The clinic blood pressure was measured in a relaxed sitting position using a standard Omron (HEM711DLX) with blood pressure apparatus on the left arm, placed at heart level after 5-minute rest and using a cuff of appropriate size with legs uncrossed. Three BP measurements were obtained with a minimum interval of one minute and average of the last two measurements was used in the present analysis. Hypertension was defined as systolic blood pressure (SBP) ≥ 140mmHg and/or diastolic blood pressure (DBP) ≥ 90mmHg or being on antihypertensive treatment.

Electrocardiography
-------------------

All participants for this study had resting 12-lead ECG, using a commercially available CONTEC® Workstation Model CONTEC EC8000G, ECG machine (Made in China) at speed of 25mm/s and 1mV/cm calibration. The entire ECG tracing used were inspected visually by the blinded ECG technicians in our non-invasive cardiology laboratory to detect technical errors, unrecorded leads and inadequate quality of tracings. Defective ones are repeated before data was extracted for use in the study. The ECG tracings were independently analyzed by the cardiologists who were unaware of the details of the clinical status of the patients. Abnormalities obtained from the ECGs were defined according to standard criteria24,25 ([Table 1](#T1){ref-type="table"}). Left ventricular hypertrophy was diagnosed using the following criteria: Sokolow-Lyon voltage (sum of the amplitudes of S wave in V1 and R wave in V5 or V6 ≥3.5 mV). Repolarization abnormalities in leads V5 and/or V6 indicated typical strain when there was down-sloping convex ST segment with an inverted asymmetrical T-wave opposite to the QRS axis26,27. QT interval was determined using the tangent method28. The measured QT interval was corrected for heart rate using the Bazett\'s formula. Prolonged QT interval was considered present when the QTc was \>450 milliseconds and \>440milliseconds in women and men respectively. Presence of other ST-T changes was documented according to standard criteria[@R24].

###### 

Definitions of ECG Variables

  --------------------------------------------------------------------------------------------------
  ECG Variables                      Definitions
  ---------------------------------- ---------------------------------------------------------------
  **Atrial fibrillation(Afib)**      Coarse fibrillatory waves, irregular QRS, rate 400--500\
                                     beats per minutes

  **Atrial flutter(Afl)**            Rate between 250 to 350 beats per minute, saw tooth\
                                     pattern P waves

  **Sinus arrhythmia**               Variation of the P-P interval, from one beat to the next, of\
                                     at least 0.12 seconds, or 120 milliseconds

  **Premature Ventricular**\         Abnormal QRS shape and QRS=≥120ms
  **Contraction(PVC)**               

  **Premature Supra**\               Presence of sinus tachycardia, atrial tachycardia, atrial\
  **ventricular**\                   fibrillation, AVNRT complexes, atrial flutter, multifocal\
  **contraction(PSVC)**              atrial tachycardia, accelerated junctional tachycardia

  **Left atrial**\                   P wave in lead II is greater than ≥ 120ms
  **enlargement(LAE)**               

  **Bi-atrial enlargement(BAE)**     P wave in lead II is greater than 120ms and higher than\
                                     ≥ 2.5mm

  **Left Ventricular**\              S~V-I~ + R~V-5~ or R~V-6~ = ≥35 mm (whether male or female)
  **hypertrophy(LVH)Sokolow-Lyon**   

  **Left Ventricular**\              S~V-I~ + R~V-5~ or R~V-6~ = ≥35 mm (whether male or female)\
  **hypertrophy with strain**        with T waves changes

  **Right Ventricular**\             R/S ratio of greater than 1 in lead V1 in the absence of\
  **hypertrophy(RVH)**               other causes or if the R wave in lead V1 is greater than 7\
                                     millimeters tall

  **P duration**                     ≤0.120seconds

  **QRS duration**                   0.80--0.120seconds

  **PR interval**                    0.12--0.20seconds

  **QT Interval**                    0.40 seconds (for males) and 0.44 seconds (for females)
  --------------------------------------------------------------------------------------------------

Definition of metabolic syndrome
--------------------------------

Metabolic syndrome was defined based on International Diabetic Federation (IDF) criteria using waist circumference (≥94cm (men), ≥80cm (female), or two or more of the following. i) Fasting triglyceride \>150g/dL or specific treatment for this lipid abnormality. ii) HDL cholesterol \< 40mg/dL(men), \<50mg/dL(women) or specific treatment for this lipid abnormality. iii) Blood pressure \>130mmHg (systolic), \>90mmHg (diastolic) or on anti-hypertensive treatment. iv)fasting plasma glucose ≥100 mg/dL or previously diagnosed diabetes mellitus.[@R29]

Data management and statistical analysis
----------------------------------------

The data was analyzed using Statistical Package for Social Sciences (SPSS), version 20.0 (IBM). The qualitative data were summarized as frequency and percentage while quantitative variables was summarized as means and standard deviations (SD). To investigate the statistical significance of the difference in continuous variables according to gender and the presence of metabolic syndrome or not, independent samples t-test was employed. For categorical variables, the Chi-square test for the comparison of proportions was employed. Association between selected demographic, clinical characteristics and ECG findings was investigated at bivariate and multivariate levels with p-value \<0.05.

Results
=======

Four hundred and ninety-one participants comprising 48.3% women with mean age 53.72±15.2 years who met the IDF criteria with complete ECG interpretations were analyzed. 44.2% (men 38.6%; women 50.2%) and 74% of the participants had MetS and ECG abnormalities respectively. As shown in [Table 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}, mean age, blood pressure parameters and waist circumference were comparable across gender. Compared to women, men had higher mean total cholesterol, creatinine, smoking, and alcohol use, and diabetes mellitus, QT prolongation, LVH plus or minus strain pattern, and ECG abnormalities in general. Women were heavier, had higher heart rate and proportions of MetS. Expectedly, participants with MetS compared with those without MetS had higher mean blood pressure, waist circumference, BMI, Triglyceride, fasting plasma glucose and smoking history. ECG findings were similar among the group.

###### 

Characteristics of Study Participant by Gender

  -----------------------------------------------------------------------------------------------
  Variables                                  Total\        Male\         Female\       p-\
                                             491 (100%)    254\          237\          Value
                                                           (51.7%)       (48.3%)       
  ------------------------------------------ ------------- ------------- ------------- ----------
  **Age (years)**                            53.72±15.2    54.37±15.5    53.03±14.8    0.328

  **Alcohol Use (%)**                        130 (26.5)    90 (35.4)     40 (16.9)     \<0.0001

  **Ex-Smoker (%)**                          114 (23.2)    82 (32.3)     32 (13.5)     \<0.0001

  **Current Smoker (%)**                     3 (0.6)       3 (1.2)       0 (0.0)       

  **Hip Circumference (cm)**                 102.13±14.7   99.68±13.6    104.77±15.5   \<0.0001

  **Waist Circumference (cm)**               93.09±14.8    91.97±15.6    94.30±13.8    0.081

  **Body Mass Index (Kg/m^2^)**              27.34±5.8     25.80±4.9     28.98±6.1     \<0.0001

  **Systolic Blood Pressure (mmHg)**         144.53±24.4   145.33±24.0   143.65±24.8   0.449

  **Diastolic Blood Pressure (mmHg)**        89.13±16.5    89.75±17.1    88.44±15.8    0.381

  **Fasting Blood Sugar (mg/dL)**            98.97±36.0    102.02±41.1   95.71±29.4    0.069

  **Urea (mg/dL)**                           28.30±17.6    30.28±21.0    26.26±12.8    0.013

  **Creatinine (mg/dL)**                     1.31±1.1      1.25±0.8      1.01±1.3      0.014

  **Total Cholesterol (mg/dL)**              185.28±45.6   180.14±46.4   190.98±44.0   0.011

  **Triglyceride (mg/dL)**                   100.99±39.4   102.90±45.1   98.89±32.0    0.275

  **Low Density Lipoprotein Cholesterol**\   117.15±38.2   114.07±37.8   120.55±38.4   0.069
  **mg/dL)**                                                                           

  **High Density Lipoprotein (mg/dL)**       47.18±17.34   44.94±16.0    49.66±18.4    0.003

  **ECG Changes**                                                                      

  **Heart Rate (beat/minute)**               84.01±18.3    81.74±17.5    86.38±19.0    0.008

  **P Duration (ms)**                        113.10±31.2   111.94±30.1   114.23±32.3   0.445

  **QRS Duration (ms)**                      113.64±30.8   115.51±30.1   111.71±31.4   0.197

  **T Duration (ms)**                        266.04±44.0   266.41±42.2   265.68±45.8   0.890

  **PR Interval (ms)**                       151.38±35.7   150.10±33.7   152.63±37.5   0.471

  **QT Interval (ms)**                       405.43±48.7   405.32±46.0   405.54±51.5   0.963

  **QTc Interval (ms)**                      475.71±70.5   469.46±71.3   482.13±69.3   0.061

  **LVH (%)**                                153 (32.7)    92 (38.2)     61 (26.9)     0.009

  **LVH with Strain Pattern (%)**            44 (9.5)      34 (14.4)     10 (4.4)      \<0.0001

  **Prolonged QT (%)**                       269 (58.0)    150 (62.8)    119 (52.9)    0.031

  **ECG Abnormalities (%)**                  356 (74.0)    199 (79.9)    157 (67.7)    0.002

  **Diabetes Mellitus (%)**                  35 (8.1)      25 (11.2)     10 (4.8)      0.014

  **MetS (%)**                               217 (44.2)    98 (38.6)     119 (50.2)    0.010
  -----------------------------------------------------------------------------------------------

###### 

Basic Demographic and Clinical Parameters versus Metabolic Syndrome

  --------------------------------------------------------------------------------------------------------------
  Variables                              Total\               Non-Metabolic\   Metabolic\    p-Value     
                                         491 (100%)           Syndrome\        Syndrome\                 
                                                              (NMetS)\         (MetS)\                   
                                                              274 (55.8%)      217 (44.2%)               
  -------------------------------------- -------------------- ---------------- ------------- ----------- -------
  **Age (years)**                        53.72±15.2           53.06±16.7       54.57±13.0    0.262       

  **Alcohol Use (%)**                    130 (26.5)           72 (26.3)        58 (26.7)     0.430       

  **Smoking Status**                     Former Smoker (%)    114 (23.2)       76 (27.7)     38 (17.5)   0.030

                                         Current Smoker (%)   3 (0.6)          0 (0.0)       3 (1.4)     

  **Occupation**                         Professional (%)     138 (28.1)       65 (23.7)     73 (33.6)   0.001

                                         Unskilled (%)        4 (0.8)          2 (0.7)       2 (0.9)     

  **Hip Circumference (cm)**             102.13±14.7          97.28±14.7       108.26±12.3   \<0.0001    

  **Waist Circumference (cm)**           93.09±14.8           87.24±13.8       100.48±12.5   \<0.0001    

  **Hip Waist Ratio**                    6.00±65.4            9.12±88.1        2.36±15.2     0.418       

  **Body Mass Index (Kg/m^2^)**          27.34±5.8            25.31±5.3        29.93±5.3     \<0.0001    

  **Waist Height Ratio**                 0.58±0.3             0.54±0.2         0.63±0.4      \<0.0001    

  **Waist Hip Ratio**                    0.93±0.4             0.92±0.5         0.93±0.1      0.787       

  **Systolic Blood Pressure**\           144.53±24.4          139.57±24.7      150.69±22.5   \<0.0001    
  **(mmHg)**                                                                                             

  **Diastolic Blood Pressure**\          89.13±16.5           86.50±16.7       92.39±15.6    \<0.0001    
  **(mmHg)**                                                                                             

  **Fasting Blood Glucose (mg/dL)**      98.97±36.0           94.72±37.5       103.94±33.7   0.008       

  **Urea (mg/dL)**                       28.30±17.6           28.92±21.2       27.55±11.5    0.401       

  **Two Hours Fasting Blood**\           121.06±55.0          111.82±49.2      130.55±59.0   0.010       
  **Sugar (mg/dL)**                                                                                      

  **Creatinine (mg/dL)**                 1.13±1.1             1.121±0.8        1.14±1.39     0.821       

  **Total Cholesterol (mg/dL)**          185.28±45.6          184.85±46.5      185.76±44.6   0.831       

  **Triglyceride (mg/dL)**               100.99±39.4          93.54±35.0       109.45±42.4   \<0.0001    

  **Low Density**\                       117.15±38.2          115.49±38.5      119.03±37.8   0.320       
  **Cholesterol (mg/dL)**                                                                                

  **High Density Lipoprotein (mg/dL)**   47.18±17.3           50.95±19.0       42.94±14.1    \<0.0001    
  --------------------------------------------------------------------------------------------------------------

[Tables 4](#T4){ref-type="table"}, [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"} depict gender differences in ECG changes and Components of MetS. In men IDF metabolic score was associated with conduction abnormalities (p=0.039) and combined ECG abnormality (p=0.042) which became more significant with the exclusion of QT prolongation (p=0.004). Also, IDF abdominal obesity was associated with QT prolongation (p=0.017), combined ECG abnormality (p=0.034), and HDLc with ECG abnormalities (0.037). No significant associations of components of metabolic syndrome with ECG abnormalities among women. [Table 7](#T7){ref-type="table"} shows that male gender and HDLc were independent predictors of ECG Abnormalities.

###### 

Comparisons of ECG abnormalities in metabolic syndrome

  Variables                     Total          Non-Metabolic Syndrome   Metabolic Syndrome   p-
  ----------------------------- -------------- ------------------------ -------------------- -------
  P Duration (ms)               113.10±31.2    111.77±33.5              114.61±28.4          0.356
  QRS Duration (ms)             113.64±30.8    115.04±32.6              112.02±28.5          0.306
  T Duration (ms)               266.04±44.0    267.63±47.6              264.19±39.5          0.515
  PR Interval (ms)              151.38±35.7    151.23±37.1              151.55±34.1          0.927
  QT Interval (ms)              405.43±48.7    407.18±51.3              403.42±45.6          0.423
  QTc Interval (ms)             475.71± 70.5   479.64± 79.9             471.20±57.9          0.203
  Left Atrial Enlargement (%)   47 (9.6)       28 (10.2)                19 (8.8)             0.787
  Bi-Atrial Enlargement (%)     11 (2.2)       7 (2.6)                  4 (1.8)              0.789
  LVH (%)                       153 (31.2)     93 (33.9)                60 (27.6)            0.324
  LV Strain Pattern (%)         44 (9.0)       26 (9.5)                 18 (8.3)             0.885
  RV Hypertrophy (%)            12 (2.4)       9 (3.3)                  3 (1.4)              0.385
  Prolonged QT interval (%)     269 (58)       146 (57.6)               123 (58.6)           0.85
  ECG Abnormalities (%)         356 (74.0)     200 (74.3)               156 (73.6)           0.917
  ECG Abnormalities {Without    255 (53.6)     152 (57.4)               103 (48.8)           0.065
  QT Abnormality} (%)                                                                        

###### 

Gender specific characteristics in metabolic syndrome

  Variables                   Male          p-Value       Female     p-Value                     
  --------------------------- ------------- ------------- ---------- ------------- ------------- ----------
  Age (years)                 53.34±17.1    56.03±12.6    0.181      52.68±16.2    53.36±13.2    0.724
  Body Mass Index (kg/m^2^)   23.87±4.3     28.93±4.2     \<0.0001   27.22±5.9     30.73±5.9     \<0.0001
  Hip Circumference (cm)      94.67±12.9    107.65±10.7   \<0.0001   100.74±16.3   108.76±13.5   \<0.0001
  Waist Circumference         84.81±12.5    103.37±12.9   \<0.0001   90.45±14.8    98.11±11.9    \<0.0001
  \(cm\)                                                                                         
  Systolic Blood Pressure     140.94±24.1   152.29±22.3   \<0.0001   137.73±25.5   149.38±22.7   \<0.0001
  (mmHg)                                                                                         
  Diastolic Blood Pressure    87.58±16.6    93.19±17.4    0.011      85.04±16.8    91.73±14.1    0.001
  (mmHg)                                                                                         
  Fasting Blood Sugar         98.03±46.0    108.25±31.3   0.070      90.07±19.6    100.59±35.1   0.010
  (mg/dL)                                                                                        
  Urea (mg/dL)                30.71±25.2    29.63±12.3    0.700      26.68±14.7    25.84±10.6    0.620
  Creatinine (mg/dL)          1.28±0.9      1.22±0.4      0.546      0.93±0.4      1.09±1.8      0.362
  Total Cholesterol           176.23±45.8   185.89±46.9   0.112      197.15±44.8   185.66±42.8   0.054
  (mg/dL)                                                                                        
  Triglyceride (mg/dL)        94.97±38.1    114.56±51.9   0.001      91.50±30.1    105.20±32.3   0.001
  Low Density Cholesterol     111.67±36.5   117.59±39.5   0.232      120.93±40.7   120.23±36.5   0.893
  (mg/dL)                                                                                        
  High Density Lipoprotein    46.92±15.4    42.05±16.7    0.020      56.65±22.1    43.67±11.6    \<0.0001
  (mg/dL)                                                                                        
  Heart Rate                  83.26±17.7    79.57±17.0    0.120      86.35±18.9    86.41±19.1    0.982
  (beats/minutes)                                                                                
  P Duration (ms)             112.01±33.7   111.84±24.3   0.968      111.49±33.4   116.81±31.2   0.233
  QRS Duration (ms)           113.85±32.2   117.85±26.9   0.332      116.53±33.2   107.19±28.9   0.029
  T Duration (ms)             267.62±42.9   264.85±41.6   0.704      267.64±2.5    263.63±37.9   0.602
  PR Interval (ms)            151.26±35.4   148.52±31.4   0.566      151.19±39.1   153.99±36.1   0.590
  QT Interval (ms)            404.36±49.8   406.67±40.2   0.713      410.67±53.1   400.73±49.7   0.158
  QTc Interval (ms)           471.51±78.6   466.59±59.9   0.614      489.71±80.7   475.02±56.1   0.121

###### 

Gender specific association between components of metabolic syndrome and ECG Abnormality

  -------------------------------------------------------------------------------------------
  Variables                Male         p-Value     Female   p-Value                  
  ------------------------ ------------ ----------- -------- ------------ ----------- -------
  IDF-\                    101 (50.8)   17 (34.0)   0.034    135 (86.0)   69 (92.0)   0.189
  Abdominal Obesity (%)                                                               

  IDF-Blood Pressure (%)   170 (81.3)   39 (78.0)   0.173    122 (78.2)   55 (75.3)   0.630

  IDF-Glucose (%)          64 (36.8)    12 (26.1)   0.175    37 (26.8)    15 (28.8)   0.460

  IDF-Triglceride (%)      21 (11.0)    5 (10.4)    0.908    9 (6.3)      6 (8.6)     0.533

  IDF-HDLc (%)             134 (70.5)   41 (85.4)   0.037    87 (60.4)    47 (67.1)   0.340
  -------------------------------------------------------------------------------------------

###### 

Determinants of ECG abnormalities in the study population

  Variable                          Odd ratio   95% Confidence Interval   P value
  --------------------------------- ----------- ------------------------- ---------
  **Age**                           1.006       0.990 -- 1.022            0.460
  **Male Gender**                   1.904       1.126 -- 3.220            0.016
  **IDF_Abdominal Obesity**         0.944       0.540 -- 1.651            0.839
  **MS_Blood Glucose**              0.825       0.490 -- 1.389            0.469
  **MS_Blood Pressure**             0.837       0.461 -- 1.519            0.558
  **MS_High Density Lipoprotein**   1.843       1.068 -- 3.180            0.028
  **MS_Triglyceride**               1.172       0.517 -- 2.661            0.704

Discussion
==========

In this study, approximately 4 out of 10 participants had MetS while three quarters had ECG abnormalities. Abnormal ECG findings were commoner in men with no differential association in people with MetS and those without MetS. However, a significant association existed between certain components of MetS and ECG abnormalities in men only.

The prevalence of 44.2% in this current study is almost twice the prevalence earlier reported by our team among the health workers. While women had excess MetS in both study cohorts, the gaps appear closing up among the gender, "34.9% vs 2.4% among health workers as against 50.2% vs 38.6%."[@R30]. Similarly, our finding of a high proportion of MetS was higher than others reported in Nigerian communities[@R31]. The rising trends may not be unconnected with equally increasing components such as obesity, hypertension, dyslipidemias and insulin resistance resulting from unhealthy lifestyles and epidemiologic transition[@R32]. May also be due to the fact that it was prevalence at a referral clinic.

Contrary to our findings, probably due to the influence of wealth and intake of atherogenic diets, Barrios and colleagues in Spain,[@R33] Ford and colleagues[@R34] in the United States, and Yassein and colleagues[@R35] in Jordan reported higher prevalence rates of 52%, 62.9%, and 52%, respectively. With a high proportion of metabolic syndrome components (high BP, 80.7%; central obesity, 67%; low HDL, 68.7% and hyperglycemia, 30%) in this cohort, MetS incidences will soon rival those of HICs. Apparently, our study population requires urgent care to prevent a possible escalation of stroke, heart failure, and Myocardial infarction associated with increasing prevalence of MetS.

Abnormalities in resting electrocardiograph (ECG) have been strongly associated with cardiovascular morbidity and mortality.[@R36] Its coexistence with MetS potentiates the rate of sudden cardiac deaths.[@R37] In this study, we report a high prevalence of ECG abnormalities and MetS. There was no association between MetS and ECG abnormalities. However, central obesity and low HDL were significantly associated with ECG abnormalities in men. Similar to our findings, Ebong et.al in MESA study reported a high prevalence of ECG in Mets which were gender specific[@R38]. However, they found associations between ECG abnormalities and MetS and its components; high blood pressure and triglyceride. The reasons for these discrepancies were not immediately obvious. Our finding, showing no association between ECG changes and MetS is similar to an earlier study in Nigeria[@R17]. Apart from the larger population in our study, gender-specific association between components of MetS and ECG abnormalities was not explored, which our study showed.

Similarly, a study in African Americans which share ancestry with blacks in sub-Saharan Africans showed high a proportion of ECG changes among their study population, so also among Caucasians[@R16],[@R39],[@R40]. Our study specifically showed a high prevalence of prolonged QTc, left ventricular hypertrophy (LVH) and LVH with strains abnormality similar to other studies[@R16]. This is not surprising since studies have shown high preponderance of LVH among blacks.[@R41],[@R42]. Left ventricular hypertrophy is an independent risk factor for stroke. Prolongation of the QT and QTc intervals is caused by the heightened sympathetic activity characteristic of obesity that increases the reduced heart rate variability; all these elements have the potential to cause arrhythmia and may lead to cardio-embolic stroke.

Previous studies have established the role of uncontrolled elevated blood pressure and other traditional cardiovascular risk factors in structural myocardial changes which are interpreted from ECG recordings[@R43]. The aggregates of these risk factors which constitutes MetS are suspected to produce more abnormal ECG changes in people with MetS compared with those without MetS. Our study did not have significant changes between the two groups. However, certain components of MetS were significantly different among men only. High frequency of hypertension among the groups may account for the insignificant ECG findings.

The implication of our findings to clinical care is that people referred for cardiac care in our center who have high aggregates of cardiovascular risk factors should have an ECG done at presentation. This is because of the high prevalence of significant abnormalities which may be due to high prevalence of hypertension and dyslipidemia, the most important drivers of ECG changes, especially among blacks.[@R17],[@R44],[@R45]

Strengths and limitation
========================

Our study has several strengths; one of such is establishing the burden of metabolic syndrome and abnormal ECG among the first timer at a cardiac clinic in Nigeria. Our findings have implications for early risk stratification of our patients for prompt management. However, the cross-sectional study design is a limitation, as the causal relationship cannot be established. Also the use of Sokolow Lyon criteria which is non sex-specific might have exaggerated our findings of LVH in men. In addition, the small sample size and hospital-based data collection limit the generalization of our findings to the general population.

Conclusion
==========

MetS and abnormal ECG changes are common among the studied population. While women had a higher prevalence of MetS, men had more abnormal ECG findings with a significant association between abdominal obesity, dyslipidemia and ECG abnormalities in men only. Larger prospective study is required to support gender - specific cardiac care in this population.
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